SSKN
STRATA Skin Sciences, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.01
+0.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 30.7M | 30.7M | 33.6M | 33.4M | 36.2M |
| Cost of Revenue | 12.9M | 12.8M | 14.5M | 14.9M | 14.4M |
| Gross Profit | 17.8M | 17.9M | 19.1M | 18.5M | 21.8M |
| Operating Expenses | |||||
| R&D Expense | 421.0K | 421.0K | 883.0K | 1.3M | 1.0M |
| SG&A Expense | 23.4M | 23.3M | 23.6M | 23.5M | 25.4M |
| General & Admin Expense | 10.4M | 10.2M | 11.3M | 10.5M | 10.1M |
| Selling & Marketing Expense | 13.0M | 13.1M | 12.3M | 13.0M | 15.3M |
| Other Expenses | — | — | 3.9M | 2.3M | — |
| Total Operating Expenses | 23.8M | 23.7M | 28.3M | 27.1M | 26.4M |
| Cost and Expenses | 36.8M | 36.5M | 42.8M | 42.0M | 40.8M |
| Operating Income (EBIT) | (6.1M) | (5.8M) | (9.3M) | (8.6M) | (4.6M) |
| Non-Operating | |||||
| Interest Income | 410.0K | 410.0K | 242.0K | 231.0K | 89.0K |
| Interest Expense | 2.0M | 2.0M | 2.1M | 1.6M | 926.0K |
| Net Interest Income | (1.5M) | (1.5M) | (1.9M) | (1.4M) | (837.0K) |
| Other Non-Op Income/Expense | (414.0K) | (414.0K) | (1.0M) | (2.3M) | (837.0K) |
| Non-Operating Income (excl Interest) | (1.0M) | (1.5M) | (1.1M) | 678.0K | (89.0K) |
| EBT (Pre-Tax Income) | (6.5M) | (6.2M) | (10.3M) | (10.9M) | (5.5M) |
| Income Tax Expense | 12.0K | 12.0K | (170.0K) | (92.0K) | 63.0K |
| Bottom Line | |||||
| Net Income | (6.5M) | (6.3M) | (10.1M) | (10.8M) | (5.5M) |
| Earnings from Cont. Ops | (6.5M) | (6.3M) | (10.1M) | (10.8M) | (5.5M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (6.5M) | (6.3M) | (10.1M) | (10.8M) | (5.5M) |
| Per Share | |||||
| Basic EPS | ($1.01) | ($1.35) | ($0.26) | ($0.31) | ($0.16) |
| Diluted EPS | ($1.01) | ($1.35) | ($0.26) | ($0.31) | ($0.16) |
| Revenue Per Share | $5.21 | $0.66 | $0.88 | $0.96 | $1.04 |
| Shares | |||||
| Basic Shares Outstanding | 5.9M | 46.5M | 38.1M | 34.9M | 34.7M |
| Diluted Shares Outstanding | 5.9M | 46.5M | 38.1M | 34.9M | 34.7M |
| Profitability Metrics | |||||
| EBITDA | (564.0K) | 177.0K | (2.8M) | (3.4M) | 1.1M |
| D&A | 4.5M | 4.5M | 5.3M | 5.9M | 5.7M |
| EBIT | (5.0M) | (4.3M) | (8.1M) | (9.3M) | (4.6M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025